Rockville, MD – March 23, 2016 – MockV Solutions, Inc. (MockV or the Company), a biotechnology company developing non-infectious viral clearance prediction products that address the unmet needs of process development scientists as they establish biopharmaceutical manufacturing platforms, announced today that it has received approval for receipt of a $100,000 convertible note from the Technology Commercialization Fund (TCF) of The Maryland Technology Development Corporation (TEDCO). As a result, the Company anticipates being able to commercialize its lead product, the MVMMVP Kit in 2017. For TEDCO’s Press release on this award, visit http://tedco.md/press/tedco-invests-1-7-million-in-17-maryland-startups/
TEDCO is the go-to source for entrepreneurial support and guidance for start-ups and early-stage companies engaged in bringing innovative ideas to market. For over fifteen years, the organization has provided funding, mentoring and networking opportunities to support Maryland’s innovation ecosystem. While founded by the Maryland General Assembly, TEDCO is an independent entity that makes seed/early-stage investments and manages private capital for angel and venture capital funds. It is frequently ranked as one of the most active seed/early-stage investors in the nation. The organization plays a key role in bringing research created in Maryland’s educational institutions and federal laboratories into the commercial marketplace. For more information on TEDCO and its programs and resources, visit www.TEDCO.md.